Form 4 for SER Serina Therapeutics, Inc.
Accepted 2024-09-16 00:00:00 ET · period of report 2024-09-12 · accession 0001493152-24-036461 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-09-16 | 2024-09-12 | SER | MINTZ STEVEN | Dir | P - Purchase | $6.47 | +6,000 | 17.4K | +52% | +$38.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-12 | P | A | 6,000 | $6.47 | 17,443 | I By Spouse | — | — | (F1) The price reflects the weighted average purchase price of multiple transactions. Upon the written request of the SEC, the issuer or a security holder of the issuer, the Reporting Person agrees to provide the number of shares sold at each sale price. |